Medidata NEXT is an immersive experience that unites 3,000 professionals in Life Sciences across seven global events. At NEXT, you’ll have the opportunity to connect with, learn from and be inspired by an array of industry thought leaders and so much more. Come see what the … Read More »

By Jim Datin, President and CEO, BioAgilytix Finding the right talent is challenging for any organization in any industry, but when you operate in a technical field that requires highly skilled workers, it can be even more difficult. Back in the late 90s during the peak of t … Read More »

Are we closer to finding a cure for MS? Attend this webinar to find out. July 11, 2018 | 10:00am ET Discover insights from the experts at GeNeuro, a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, about the first clini … Read More »

By Jim Datin, President and CEO of BioAgilytix There are a number of factors driving rapid growth of the global biologics market today. For one, pharmaceutical and biotech companies are shifting more investment into the discovery and development of large molecule therapeutic … Read More »

by Carlos Rodarte, Founder & Managing Director, Volar Health, LLC This is part two of a three-part series that discusses how enhanced access to in-depth health data is impacting our understanding of personhood, the environment around us, and the pharma model. Our Environ … Read More »

by Carlos Rodarte, Founder & Managing Director, Volar Health, LLC This is part one of a three-part series that will discuss how enhanced access to in-depth health data is impacting our understanding of personhood, the environment around us, and the pharma model. A New Un … Read More »

What do you get when Senior Pharmaceutical Executives get together and brainstorm about disruptive innovation in the Life Sciences industry? You get some pretty interesting perspectives, and perhaps even a glimpse into the future. Early in 2018, ICON gathered a group of indu … Read More »

Hundreds of visionaries will be descending on Aspen, Colorado from June 21-24 for the Aspen Ideas Festival: Spotlight Health. This three-day health conference features an exceptional mix of inspiring and provocative experts who dive into the latest topics in medicine, scienc … Read More »

NORD’s 35th Anniversary Celebration presenting the 2018 Rare Impact Awards will be held on May 17, 2018, in Washington, D.C. at the Andrew W. Mellon Auditorium. This event will celebrate the efforts to help the 30 million Americans with rare diseases who, by the very nature … Read More »

Every once in a while a story comes along that grabs you, inspires you, and motivates you. This is one of those stories. A March 26, 2018 article in Forbes provides an in-depth profile of Kathy Giusti, Founder of the Multiple Myeloma Research Foundation (MMRF) and Co-Chair o … Read More »

From drug discovery to clinical practice, a brand journey requires connected thinking. Connected thinking includes these critical skill sets: Identify the KOL landscape – with real segmentation around mindset and behavior Understand the science – with insight and vision Craf … Read More »

The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients and provided incentives to pharmaceutical manufacturers, including tax credits for the costs of clinical research, seven years of patent exclusivity, and the waiv … Read More »

For many, a career in the life-sciences industry means far more than just a paycheck. It’s about advancing medicine, improving lives and patient care, and innovating new ways of addressing challenges. Most people you meet in this industry have a story about why they chose th … Read More »

It’s an exciting, yet challenging time for clinical research. Technology innovations open up a world of data for researchers and the ability to collect it faster. It’s all good news—better accuracy, more data-driven decisions and improved treatment for patients. But there’s … Read More »

by Adele Gulfo Biopharmaceutical Executive PharmaVOICE 100 Honoree — 2007 and 2016 As I was on the NYC Subway headed toward the PharmaVOICE 100 Celebration last September to participate on a panel tasked with the following question: “Collaboration: why aren’t we making progr … Read More »

By Brent Saunders, CEO, Allergan As a young executive at Schering-Plough, I learned a lot from Fred Hassan about the importance of ‘Being Connected’ and ‘Tuning In’ to customers by spending time with them and our front-line sales teams. It was the best way to understand thei … Read More »

The rise of health-related social media (SM) has been phenomenal. It has been estimated that there are over 2.5 billion patient posts from 50 million healthcare users. Health-related SM is increasingly recognized as a potentially important source of evidence. Studies are alr … Read More »

In the Fall issue of The Evidence Forum, one of the many informative articles discusses access options for investigational products, comparing and contrasting three key categories. These programs provide an important service in allowing select patient populations to receive … Read More »

In the Fall issue of The Evidence Forum, one of the many informative articles covers the promising opportunities of regenerative medicine in reversing or significantly impacting the progression of – and costs associated with – serious illnesses. These treatments have the pot … Read More »

In the November issue of The Evidence Forum, one of the informative articles covers patient engagement and retention, two key issues in clinical studies. We’ve all heard the buzz about patient-centricity. In this article, learn how a patient-centric approach can improve pati … Read More »